Vicus Capital’s Thermo Fisher Scientific TMO Stock Holding History

Vicus Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$257K	Buy	+380	New	+$226K	0.02%	252
2024 Q4	–	Sell	-343	Closed	-$212K	–	253
2024 Q3	$212K	Sell	343 -499	-59%	-$295K	0.02%	208
2024 Q2	$465K	Buy	842 +66	+9%	+$37.8K	0.04%	167
2024 Q1	$451K	Buy	+776	New	+$435K	0.04%	164
2023 Q4	–	Sell	-679	Closed	-$344K	–	255
2023 Q3	$344K	Buy	+679	New	+$362K	0.04%	182
2021 Q2	–	Sell	-514	Closed	-$235K	–	233
2021 Q1	$235K	Buy	514 +14	+3%	+$6.68K	0.03%	210
2020 Q4	$233K	Buy	+500	New	+$234K	0.03%	203

Other funds holding TMO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Vicus Capital's TMO Position: Q3 2026 in Review

Vicus Capital opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 380 shares worth $257K. The stake represents 0.02% of the portfolio and ranks #252 among its holdings. This is a return to the name: Vicus Capital previously reported a position in TMO as recently as Q3 2024.

Vicus Capital first reported a position in TMO in Q4 2020 and has held it in 7 quarters since. The position peaked at $465K in Q2 2024. 1,615 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Vicus Capital held 380 shares of Thermo Fisher Scientific worth $257K as of Q3 2026.
Thermo Fisher Scientific was a new Vicus Capital position in Q3 2026.
Thermo Fisher Scientific made up 0.02% of Vicus Capital's portfolio in Q3 2026, its #252 holding.
Vicus Capital first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 7 quarters since.
Vicus Capital's Thermo Fisher Scientific position peaked at $465K in Q2 2024.
1,615 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Vicus Capital's 13F filing for Q3 2026, filed 5 Nov 2026.